Stockholders' Equity Attributable to Parent in USD of Axcella Health Inc. from Q4 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Axcella Health Inc. quarterly Stockholders' Equity Attributable to Parent history and change rate from Q4 2017 to Q2 2023.
  • Axcella Health Inc. Stockholders' Equity Attributable to Parent for the quarter ending 30 Jun 2023 was -$2.26M, a 124% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

Axcella Health Inc. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2023 -$2.26M -$11.6M -124% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $727K -$29.2M -97.6% 31 Mar 2023 10-Q 03 Aug 2023
Q4 2022 $4.16M -$17.8M -81.1% 31 Dec 2022 10-Q 03 Aug 2023
Q3 2022 -$7.55M -$43.1M -121% 30 Sep 2022 10-Q 01 Nov 2022
Q2 2022 $9.3M -$38.8M -80.7% 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 $29.9M -$31.8M -51.5% 31 Mar 2022 10-Q 03 Aug 2023
Q4 2021 $22M -$53.4M -70.8% 31 Dec 2021 10-Q 03 Aug 2023
Q3 2021 $35.6M -$53.2M -59.9% 30 Sep 2021 10-Q 01 Nov 2022
Q2 2021 $48.1M -$44.9M -48.3% 30 Jun 2021 10-Q 01 Nov 2022
Q1 2021 $61.7M +$14.8M +31.7% 31 Mar 2021 10-Q 01 Nov 2022
Q4 2020 $75.4M +$15.2M +25.2% 31 Dec 2020 10-K 30 Mar 2023
Q3 2020 $88.8M +$14.4M +19.4% 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $93M +$3.02M +3.36% 30 Jun 2020 10-Q 10 Nov 2021
Q1 2020 $46.8M +$207M 31 Mar 2020 10-Q 10 Nov 2021
Q4 2019 $60.2M +$210M 31 Dec 2019 10-K 30 Mar 2022
Q3 2019 $74.3M +$215M 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 $89.9M +$223M 30 Jun 2019 10-Q 12 Nov 2020
Q1 2019 -$160M -$36.1M -29.1% 31 Mar 2019 10-Q 12 Nov 2020
Q4 2018 -$150M -$33.4M -28.7% 31 Dec 2018 10-K 17 Mar 2021
Q3 2018 -$141M 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$133M 30 Jun 2018 10-Q 12 Nov 2019
Q1 2018 -$124M 31 Mar 2018 10-Q 12 Nov 2019
Q4 2017 -$116M 31 Dec 2017 10-K 23 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.